These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21865662)

  • 41. Acute effect of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with multiple sclerosis: urodynamic study.
    Kabay SC; Yucel M; Kabay S
    Urology; 2008 Apr; 71(4):641-5. PubMed ID: 18387393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detrusor contraction duration as a urodynamic parameter of bladder outlet obstruction for evaluating men with lower urinary tract symptoms.
    Ameda K; Steele GS; Sullivan MP; Stember D; Yalla SV
    J Urol; 1998 Aug; 160(2):482-6. PubMed ID: 9679903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity.
    Reitz A; Denys P; Fermanian C; Schurch B; Comperat E; Chartier-Kastler E
    Eur Urol; 2007 Dec; 52(6):1729-35. PubMed ID: 17884281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detrusor after-contraction is associated with bladder outlet obstruction.
    Cho SY; Yi JS; Park JH; Jeong MS; Oh SJ
    Neurourol Urodyn; 2011 Sep; 30(7):1361-5. PubMed ID: 21560154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extracorporeal magnetic stimulation is of limited clinical benefit to women with idiopathic detrusor overactivity: a randomized sham controlled trial.
    Morris AR; O'Sullivan R; Dunkley P; Moore KH
    Eur Urol; 2007 Sep; 52(3):876-81. PubMed ID: 17335962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Traces: making sense of urodynamics testing--Part 9: Evaluation of sensations detrusor response to bladder filling.
    Gray M
    Urol Nurs; 2012; 32(1):21-8, 18. PubMed ID: 22474862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome.
    Chung SD; Liao CH; Chen YC; Kuo HC
    Neurourol Urodyn; 2011 Sep; 30(7):1300-4. PubMed ID: 21560153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity.
    Shahab N; Seki N; Takahashi R; Kajioka S; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2009; 28(8):953-8. PubMed ID: 19260093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics.
    Kuo HC
    Neurourol Urodyn; 2011 Sep; 30(7):1242-8. PubMed ID: 21560152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity.
    Nitti VW; Rovner ES; Bavendam T
    BJU Int; 2010 May; 105(9):1268-75. PubMed ID: 19889062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in urethral function with bladder filling in the presence of urodynamic stress incontinence and detrusor overactivity.
    Chaliha C; Digesu GA; Hutchings A; Khullar V
    Am J Obstet Gynecol; 2005 Jan; 192(1):60-5. PubMed ID: 15672004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Event driven electrical stimulation of the dorsal penile/clitoral nerve for management of neurogenic detrusor overactivity in multiple sclerosis.
    Fjorback MV; Rijkhoff N; Petersen T; Nohr M; Sinkjaer T
    Neurourol Urodyn; 2006; 25(4):349-55. PubMed ID: 16673380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pain during ice water test distinguishes clinical bladder hypersensitivity from overactivity disorders.
    Mukerji G; Waters J; Chessell IP; Bountra C; Agarwal SK; Anand P
    BMC Urol; 2006 Dec; 6():31. PubMed ID: 17192176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
    Kuo HC
    Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
    Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
    Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detrusor pressure in cystometry compared to physiological filling in patients with a reflex urinary bladder after spinal cord injury.
    Thyberg M; Spångberg A; Lassvik C
    Scand J Rehabil Med; 1990; 22(3):145-50. PubMed ID: 2244192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions.
    Kuo HC
    J Urol; 2003 Sep; 170(3):835-9. PubMed ID: 12913711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detrusor overactivity persisting at night and preceding nocturia in patients with overactive bladder syndrome: a nocturnal cystometrogram and polysomnogram study.
    Krystal AD; Preud'homme XA; Amundsen CL; Webster GD
    J Urol; 2010 Aug; 184(2):623-8. PubMed ID: 20639027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
    Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
    Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pilot study of Connexin 43 (Cx43) in human bladder tissue in patients with idiopathic detrusor overactivity.
    Kuhn A; Stadlmayr W; Monga A; Cameron I; Anthony F
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):83-6. PubMed ID: 18687515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.